Multiepitope Peptide Vaccination in Melanoma

Clinical trial NCT00153569 · UNKNOWN

Trial details

NCT number: NCT00153569
Sponsor: Charite University, Berlin, Germany
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Melanoma

Start date: 2003-03-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.